SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOrigin Regulatory News (OGN)

Share Price Information for Origin (OGN)

Share Price is delayed by 15 minutes
Get Live Data
397.50    0.00 (0.00%)
Bid:
385.00
Ask:
410.00
Spread: 25.00 (6.494%)
Market Cap: £427.26m
OGN Live PriceLast checked at - London Stock Exchange

Intraday Origin Share Chart

Directorate Changes

29 Sep 2022 07:00

RNS Number : 0756B
Origin Enterprises Plc
29 September 2022
 
Origin Enterprises plc

 

Appointment of Non-Executive Director and Board Committee Changes

 

Alan Ralph joins Origin as an independent Director

 

Dublin, London, 29 September 2022: Origin Enterprises plc ('Origin' or 'the Group'), the international Agronomy-Services Group providing specialist advice, inputs and digital solutions to promote sustainable land use, is pleased to announce the appointment of Mr Alan Ralph to the Board as an independent Non-Executive Director, with effect from 3 October 2022. Origin also announces Senior Independent Director and Board Committee changes, which will take effect following the conclusion of the Company's Annual General Meeting ('AGM') on 22 November 2022.

 

New independent Non-Executive Director

Alan Ralph (53) is a highly experienced business professional and financial leader having spent 20 years with UDG Healthcare plc. He spent 10 years leading UDG's largest business unit before supporting the company's strategic transformation as Chief Financial Officer for five years. Alan is a Fellow of Chartered Accountants Ireland and previously worked in Banta Corporation and PwC. 

 

Alan was nominated to the Board following a thorough recruitment process led by the Nomination and Corporate Governance Committee. He also currently serves as a Non-Executive Director of DCC plc and is Chair of their Audit Committee.

 

As of today, Alan holds interests in 10,000 Ordinary Shares of Origin, representing approximately 0.009% of the Company's issued share capital, excluding treasury shares. 

 

Senior Independent Director and Board Committee Changes

In June 2022, the Group announced that Gary Britton was appointed Chair Designate to succeed Rose Hynes at the 2022 AGM. At that time, he will also assume the role of Chair of the Nomination and Corporate Governance Committee and join the Remuneration Committee as a member. Alan Ralph will become Chair of the Audit and Risk Committee and a member of the Nomination and Corporate Governance Committee.

 

Helen Kirkpatrick has been appointed as Origin's Senior Independent Director to replace Gary Britton at the conclusion of the AGM, when she will also step down as a member of the ESG Committee. The ESG Committee membership otherwise remains consistent, with Lesley Williams in the role of Chair of the Committee since 1 August 2022.

 

Rose Hynes, Chairman of Origin, commented:

"As part of our ongoing evaluation of Board composition and in planning for Gary Britton to transition into the role of Chairman following the AGM in November 2022, we are pleased to provide an update on a number of Board positions. We undertook a comprehensive recruitment process for the appointment of a new Non-Executive Director, culminating in the appointment of Alan Ralph. I am delighted to welcome Alan to the Board and look forward to the contribution his financial expertise and extensive business experience will provide Origin through its next phase of growth and development.

 

Helen Kirkpatrick has been appointed as the Company's new Senior Independent Director in line with our succession planning and our Committee memberships will be refreshed to reflect the skillsets and experience of the Board as a whole."

 

The following information in respect of Alan Ralph is disclosed pursuant to Rule 17 of the AIM Rules for Companies:

 

Current Directorships: 

DCC plc

Killarney Glen Owners Management Company Limited by Guarantee

 

Directorships held in the last 5 years:

Aquilant Limited

Aquilant Scientific (ROI) Limited

Ashfield Alliance Limited

Dublin Drug (Investments) Limited

Dublin Drug Company Limited

Dublin Drug Public Limited Company

UDG Healthcare (US) Holdings Limited

UDG Healthcare Ayrtons (Dublin) Limited

UDG Healthcare Finance Limited

UDG Healthcare Ireland Limited

UDG Healthcare plc

UDG Healthcare Nordic Limited

UDG Healthcare Property Holdings Limited

United Care Limited

 

 

ENDS

 

There is no other information that is required to be disclosed in accordance with Rule 17, Schedule 2 paragraph (g) of the AIM Rules for Companies.

 

Enquiries

 

Origin Enterprises plc

TJ Kelly

Chief Financial Officer

 

Tel:

+353 (0)1 563 4959

 

Brendan Corcoran

Head of Investor Relations and Group Planning

 

Tel:

 

+353 (0)1 563 4900

 

Goodbody (Euronext Growth (Dublin) Adviser)

Finbarr Griffin

 

Tel:

 

+353 (0)1 641 9278

 

Davy (Nominated Adviser) Anthony Farrell

 

Tel:

 

+353 (0)1 614 9993

 

Numis Securities (Stockbroker) Stuart Skinner

 

Tel:

 

+44 (0)20 7260 1314

 

FTI Consulting (Financial Communications Advisers) Jonathan Neilan/ Patrick Berkery

 

Tel:

 

+353 (0)1 765 0884

About Origin Enterprises plc

 

Origin Enterprises plc is an international Agronomy-Services group, providing specialist advice, inputs, services and digital solutions to promote sustainable land use. The Group has leading market positions in Ireland, the United Kingdom, Brazil, Poland, Romania and Ukraine. Origin is listed on the Euronext Growth (Dublin) and AIM markets of the Irish and London Stock Exchanges.

 

Euronext Growth (Dublin) ticker symbol:

OIZ

AIM ticker symbol:

OGN

Website:

www.originenterprises.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFZGZLRRRGZZM
Date   Source Headline
14th Apr 20227:00 amRNSTransactions in Own Shares
13th Apr 20225:41 pmRNSHolding(s) in Company
13th Apr 20227:00 amRNSTransactions in Own Shares
12th Apr 20227:00 amRNSTransactions in Own Shares
11th Apr 20227:00 amRNSTransactions in Own Shares
8th Apr 20227:00 amRNSTransactions in Own Shares
8th Apr 20227:00 amRNSTrading Update and Earnings Guidance
7th Apr 20223:39 pmRNSHolding(s) in Company
7th Apr 20227:00 amRNSTransactions in Own Shares
6th Apr 20227:00 amRNSTransactions in Own Shares
5th Apr 20227:00 amRNSTransactions in Own Shares
4th Apr 20229:51 amRNSTransactions in Own Shares
1st Apr 20227:00 amRNSTransactions in Own Shares
31st Mar 20227:00 amRNSTransactions in Own Shares
30th Mar 20225:08 pmRNSHolding(s) in Company
30th Mar 20227:00 amRNSTransactions in Own Shares
29th Mar 20227:00 amRNSTransactions in Own Shares
28th Mar 20227:00 amRNSTransactions in Own Shares
25th Mar 20226:16 pmRNSHolding(s) in Company
25th Mar 20227:00 amRNSTransactions in Own Shares
24th Mar 20224:59 pmRNSHolding(s) in Company
24th Mar 20227:00 amRNSTransactions in Own Shares
23rd Mar 20225:43 pmRNSHolding(s) in Company
23rd Mar 20227:00 amRNSTransactions in Own Shares
22nd Mar 20227:00 amRNSTransactions in Own Shares
21st Mar 20227:00 amRNSTransactions in Own Shares
18th Mar 20227:00 amRNSTransactions in Own Shares
17th Mar 20223:11 pmRNSHolding(s) in Company
17th Mar 20227:00 amRNSTransactions in Own Shares
16th Mar 20221:49 pmRNSHolding(s) in Company
16th Mar 20221:46 pmRNSHolding(s) in Company
16th Mar 20227:00 amRNSTransactions in Own Shares
15th Mar 20222:07 pmRNSHolding(s) in Company
15th Mar 20227:00 amRNSTransactions in Own Shares
14th Mar 20223:35 pmRNSDirector/PDMR Shareholding
14th Mar 20223:31 pmRNSDirector/PDMR Shareholding
14th Mar 20227:00 amRNSTransactions in Own Shares
11th Mar 20227:00 amRNSTransactions in Own Shares
10th Mar 20227:46 amRNSTransactions in Own Shares
9th Mar 20225:03 pmRNSInterim Dividend Record Date
8th Mar 20227:15 amRNSEUR40 Million Share Buyback Programme
8th Mar 20227:00 amRNSInterim Results Statement
22nd Feb 20224:54 pmRNSRe-issue of Treasury Shares
4th Feb 20224:35 pmRNSHolding(s) in Company
3rd Feb 20222:27 pmRNSHolding(s) in Company
11th Jan 20223:58 pmRNSHolding(s) in Company
6th Jan 20223:33 pmRNSDirector/PDMR Shareholding
3rd Dec 20211:32 pmRNSHolding(s) in Company
25th Nov 20215:03 pmRNSResult of AGM
25th Nov 20217:00 amRNSQ1 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.